Home » Stocks » TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP)

Stock Price: $0.980 USD -0.060 (-5.77%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $0.955 -0.025 (-2.52%) Apr 16, 7:59 PM
Market Cap 317.44M
Revenue (ttm) n/a
Net Income (ttm) -52.17M
Shares Out 94.59M
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $0.980
Previous Close $1.040
Change ($) -0.060
Change (%) -5.77%
Day's Open 1.010
Day's Range 0.935 - 1.010
Day's Volume 13,368,382
52-Week Range 0.510 - 2.460

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

These high-risk, high-reward healthcare stocks have outperformed the market over the past year.

Other stocks mentioned: TRVN
3 days ago - The Motley Fool

CHATHAM, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

1 week ago - GlobeNewsWire

Company Expects to Initiate a Phase 2 Clinical Trial in the Fourth Quarter of 2021, Pending Results of Toxicology Studies Company Expects to Initiate a Phase 2 Clinical Trial in the Fourth Quarter of 20...

3 weeks ago - GlobeNewsWire

CHATHAM, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the U.S. Pat...

4 weeks ago - GlobeNewsWire

Amid risk-on sentiment, penny stocks are surging higher today as investors seek to grab the higher upside these small-cap stocks provide. The post Top Penny Stocks News Today: TNXP, ONTX, AREC, LPCN and...

Other stocks mentioned: AREC, LPCN, ONTX, ZCMD
1 month ago - InvestorPlace

The company reported positive results from a pre-clinical study.

1 month ago - The Motley Fool

Tonix Pharmaceuticals (TNXP) stock is soaring higher after the company provided an update on its vaccine for the novel coronavirus. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are Soaring Toda...

1 month ago - InvestorPlace

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) jumps in premarket trading after announcing positive preliminary results following vaccination of non-human primates with TNX-1800, its COVID-19 vaccine...

1 month ago - Benzinga

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission

1 month ago - GlobeNewsWire

Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia

1 month ago - GlobeNewsWire

If you're in the market for a clinical-stage biotechnology stock that has a Covid-19 association and much more, then check out TNXP stock. The post Try Tonix Pharmaceuticals as Packed Pipeline Addresses...

1 month ago - InvestorPlace

CHATHAM, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has regai...

1 month ago - GlobeNewsWire

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has licensed technology using oxytocin-based therapeutics from the French National Institute of Health and Medical Research (Inserm) for the treatment o...

2 months ago - Benzinga

Expands Proprietary Uses of Tonix's Potentiated Oxytocin for Intranasal Administration

2 months ago - GlobeNewsWire

CHATHAM, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

2 months ago - GlobeNewsWire

CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing o...

2 months ago - GlobeNewsWire

The biotech wants to help doctors measure T-cell immunity to the novel coronavirus.

2 months ago - The Motley Fool

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has entered into a securities purchase agreement with institutional investors to purchase 58.3 million shares at $1.20 per share, raising gross proceeds...

2 months ago - Benzinga

CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has entere...

2 months ago - GlobeNewsWire

Annovis Bio (NYSE: ANVS) shares were trading higher Thursday after the company announced the European Patent Office granted the company's patent for a method of treating acute nerve and brain injuries b...

Other stocks mentioned: ANVS
2 months ago - Benzinga

TNXP stock is on the move today as investors speculate over potential patent approval and Tonix's drug candidate for Alzheimer's. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move To...

2 months ago - InvestorPlace

Tonix Pharmaceuticals was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in this article in no way represents investmen...

2 months ago - Benzinga

GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021

3 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 13, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing o...

3 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has entere...

3 months ago - GlobeNewsWire

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

3 months ago - GlobeNewsWire

This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?

Other stocks mentioned: BIOL, JAGX, SENS
3 months ago - Benzinga

Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19

3 months ago - GlobeNewsWire

University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes

3 months ago - GlobeNewsWire

Tonix Pharmaceuticals (TNXP) news for Monday includes results from a recent Phase 3 clinical trial boosting TNXP stock higher. The post Tonix Pharmaceuticals News: TNXP Stock Soars on Fibromyalgia Drug ...

4 months ago - InvestorPlace

Covid-19 Is Not Going to Go Away: Tonix Pharmaceuticals CEO

YouTube video

Dec.06 -- Seth Lederman, chairman and chief executive officer of Tonix Pharmaceuticals, talks about the coronavirus outbreak and the rollout of vaccines. Tonix has two Covid-19 vaccine in the pipeline.

4 months ago - Bloomberg Markets and Finance

Anti-SARS-CoV-2 Neutralizing Antibodies Elicited in All Eight TNX-1800 Vaccinated Animals

5 months ago - GlobeNewsWire

Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or Analyzing PTSD Symptom Change Over Time

5 months ago - GlobeNewsWire

With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech Pe...

Other stocks mentioned: CANF, FPRX, GTBP, IFRX, VTVT, VXRT
5 months ago - InvestorPlace

CHATHAM, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

5 months ago - GlobeNewsWire

CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

5 months ago - GlobeNewsWire

Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020

5 months ago - GlobeNewsWire

Study May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics

6 months ago - GlobeNewsWire

CHATHAM, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman...

6 months ago - GlobeNewsWire

Topline Results of Full Study Expected Fourth Quarter 2020

6 months ago - GlobeNewsWire

Facility Addresses the Shortage of Vaccine Production Capacity in the U.S.

6 months ago - GlobeNewsWire

Webinar to be Moderated by Clive Cookson of the Financial Times on September 24, 2020

7 months ago - GlobeNewsWire

Results from COV-LOGIC Study Expected in First Half of 2021 Results from COV-LOGIC Study Expected in First Half of 2021

7 months ago - GlobeNewsWire

Interim Analysis Results from Ongoing Phase 3 RELIEF Study Expected in September; Topline Results Expected in Fourth Quarter 2020

7 months ago - GlobeNewsWire

NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

7 months ago - GlobeNewsWire

Preclinical data for TNX-1800, a Vaccine Candidate to Protect Against COVID-19, Expected in Fourth Quarter 2020

8 months ago - GlobeNewsWire

NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Dru...

8 months ago - GlobeNewsWire

Penny stocks will always be risky. That said, with the huge disconnect we’re seeing in the markets, now may be a time to gamble.

Other stocks mentioned: IDEX, SOLO, TDRYD, XSPA, ZOM
8 months ago - InvestorPlace

NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced that it has regained complia...

8 months ago - GlobeNewsWire

Their share prices are predicted to bounce back strongly

Other stocks mentioned: CLSK
8 months ago - GuruFocus

About TNXP

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead... [Read more...]

Industry
Biotechnology
Founded
2007
CEO
Seth Lederman
Employees
26
Stock Exchange
NASDAQ
Ticker Symbol
TNXP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for TNXP stock is "Strong Buy" and the 12-month stock price forecast is 3.88.

Price Target
$3.88
Analyst Consensus: Strong Buy